AMH Test
An AMH test measures your anti-Müllerian hormone and gives insight into your ovarian reserve. Any cycle day works.
In the ovaries of women after puberty, anti-Müllerian hormone, AMH for short, is important for the growth and maturation of the egg sacs, in which eggs mature, according to the NVKC. The support cells of those sacs make the hormone, which is why the AMH value shows how large the follicle supply is.
In polycystic ovary syndrome (PCOS) AMH is strongly raised, and over the years, after surgery on an endometriosis cyst or, in women of reproductive age, after chemotherapy for breast cancer it can fall. Only a blood test shows the value.
Diagnostiek voor U uses its own limit per year of age for women, for example 0.63 to 4.54 µg/l at 35 and 0.24 to 2.83 µg/l at 40. A high AMH does not establish PCOS on its own.
Doctor's Assessment Included
AMH is a measure of the follicle supply in the ovaries, and in women the value falls with age. Star-SHL, Unilabs, Certe and Diagnostiek voor U use limits per age for women.
See the value that applies to you:
Choose male or female — this range differs by sex.
Enter your age — this range changes with age.
This range also depends on context such as cycle phase or sample material; the highlighted rows apply to your group.
| Sex | Age | Reference range (ug/l) | Relative scale |
|---|---|---|---|
| Female | · 20–24 years | 1,52–9,95 ug/l |
1,52
9,95
|
| Female | · 25–29 years | 1,2–9,05 ug/l |
1,2
9,05
|
| Female | · 30–34 years | 0,71–7,59 ug/l |
0,71
7,59
|
| Female | · 35–39 years | 0,41–6,96 ug/l |
0,41
6,96
|
| Female | · 40–44 years | 0,06–4,44 ug/l |
0,06
4,44
|
| Female | · 45–50 years | < 1,79 ug/l |
1,79
|
Package-insert value: 5th-95th percentile per age group (n = 148 men; 150 at 20-24 years; 150 at 25-29; 138 at 30-34; 138 at 35-39; 142 at 40-44; 169 at 45-50 years). AMH does not depend on the menstrual cycle and can be measured on any cycle day. The reference group did not use hormonal contraception: combined contraception lowers AMH, so a value taken while on the pill can come out low. The lower limit of 0.010 at 45-50 years is the detection limit of the test, not a measured percentile. A hormone reference value is assay-specific; these values apply to the Roche Elecsys method.
Source: Roche Diagnostics Reference population: Roche reference cohort (Elecsys AMH Plus package insert)
Reference ranges may vary between laboratories. When you order a test, a BIG-registered doctor assesses your personal results in context. For treatment decisions, discuss your results with your GP.
Check your own value| Laboratory | Group | Reference value (ug/l) | Relative scale |
|---|---|---|---|
| Star-shl | · Female · 20–24 years | 1.52–9.95 µg/l |
1.52 9.95
|
| Star-shl | · Female · 25–29 years | 1.20–9.05 µg/l |
1.2 9.05
|
| Star-shl | · Female · 30–34 years | 0.71–7.59 µg/l |
0.71 7.59
|
| Star-shl | · Female · 35–39 years | 0.41–6.96 µg/l |
0.41 6.96
|
| Star-shl | · Female · 40–44 years | 0.06–4.44 µg/l |
0.06 4.44
|
| Star-shl | · Female · 45–50 years | 0.01–1.79 µg/l |
0.01 1.79
|
| Unilabs | · Female · 20–25 years | 1.22–11.70 µg/l |
1.22 11.7
|
| Unilabs | · Female · 25–30 years | 0.89–9.85 µg/l |
0.89 9.85
|
| Unilabs | · Female · 30–35 years | 0.58–8.13 µg/l |
0.58 8.13
|
| Unilabs | · Female · 35–40 years | 0.15–7.49 µg/l |
0.15 7.49
|
| Unilabs | · Female · 40–45 years | 0.03–5.47 µg/l |
0.03 5.47
|
| Unilabs | · Female · 45–50 years | 0.01–2.71 µg/l |
0.01 2.71
|
| Unilabs | · Female · 50 years and older | 0.00–0.05 µg/l |
0 0.05
|
| Certe | · Female · 20–25 years | 1.22–11.70 ug/L |
1.22 11.7
|
| Certe | · Female · 25–30 years | 0.89–9.85 ug/L |
0.89 9.85
|
| Certe | · Female · 30–35 years | 0.576–8.130 ug/L |
0.576 8.13
|
| Certe | · Female · 35–40 years | 0.147–7.490 ug/L |
0.147 7.49
|
| Certe | · Female · 40–45 years | 0.027–5.470 ug/L |
0.027 5.47
|
| Certe | · Female · 45–50 years | 0.01–2.71 ug/L |
0.01 2.71
|
| Diagnostiek voor U | · Female · 19–20 years | 1.22–5.97 µg/L |
1.22 5.97
|
| Diagnostiek voor U | · Female · 21 years | 1.30–6.12 µg/L |
1.3 6.12
|
| Diagnostiek voor U | · Female · 22 years | 1.35–6.28 µg/L |
1.35 6.28
|
| Diagnostiek voor U | · Female · 23 years | 1.41–6.45 µg/L |
1.41 6.45
|
| Diagnostiek voor U | · Female · 24 years | 1.36–6.62 µg/L |
1.36 6.62
|
| Diagnostiek voor U | · Female · 25 years | 1.32–6.79 µg/L |
1.32 6.79
|
| Diagnostiek voor U | · Female · 26 years | 1.26–6.88 µg/L |
1.26 6.88
|
| Diagnostiek voor U | · Female · 27 years | 1.20–6.83 µg/L |
1.2 6.83
|
| Diagnostiek voor U | · Female · 28 years | 1.15–6.74 µg/L |
1.15 6.74
|
| Diagnostiek voor U | · Female · 29 years | 1.11–6.52 µg/L |
1.11 6.52
|
| Diagnostiek voor U | · Female · 30 years | 1.07–6.32 µg/L |
1.07 6.32
|
| Diagnostiek voor U | · Female · 31 years | 0.96–5.97 µg/L |
0.96 5.97
|
| Diagnostiek voor U | · Female · 32 years | 0.87–5.63 µg/L |
0.87 5.63
|
| Diagnostiek voor U | · Female · 33 years | 0.79–5.26 µg/L |
0.79 5.26
|
| Diagnostiek voor U | · Female · 34 years | 0.69–4.87 µg/L |
0.69 4.87
|
| Diagnostiek voor U | · Female · 35 years | 0.63–4.54 µg/L |
0.63 4.54
|
| Diagnostiek voor U | · Female · 36 years | 0.55–4.19 µg/L |
0.55 4.19
|
| Diagnostiek voor U | · Female · 37 years | 0.47–3.85 µg/L |
0.47 3.85
|
| Diagnostiek voor U | · Female · 38 years | 0.39–3.52 µg/L |
0.39 3.52
|
| Diagnostiek voor U | · Female · 39 years | 0.31–3.15 µg/L |
0.31 3.15
|
| Diagnostiek voor U | · Female · 40 years | 0.24–2.83 µg/L |
0.24 2.83
|
| Diagnostiek voor U | · Female · 41 years | 0.20–2.54 µg/L |
0.2 2.54
|
| Diagnostiek voor U | · Female · 42 years | 0.14–2.29 µg/L |
0.14 2.29
|
| Diagnostiek voor U | · Female · 43 years | 0.09–2.05 µg/L |
0.09 2.05
|
| Diagnostiek voor U | · Female · 44 years | 0.07–1.80 µg/L |
0.07 1.8
|
| Diagnostiek voor U | · Female · 45 years | 0.05–1.55 µg/L |
0.05 1.55
|
| Diagnostiek voor U | · Female · 46 years | 0.04–1.44 µg/L |
0.04 1.44
|
| Diagnostiek voor U | · Female · 47 years | 0.03–1.32 µg/L |
0.03 1.32
|
| Diagnostiek voor U | · Female · 48 years | 0.02–1.21 µg/L |
0.02 1.21
|
| Diagnostiek voor U | · Female · 49 years | 0.01–1.11 µg/L |
0.01 1.11
|
| Diagnostiek voor U | · Female · 50 years · a limit, not a range | < 1.01 µg/L |
1.01
|
| Diagnostiek voor U | · Female · 52 years and older · a limit, not a range · after menopause | < 0.1 µg/L |
0.1
|
Source: Star-shl
Source: Unilabs
Source: Certe
Source: Diagnostiek voor U
Each value as the laboratory itself publishes it, retrieved in 2026.
The result gives AMH as a concentration in the blood, in micrograms per litre (µg/l). According to the Dutch guideline for the basic fertility work-up (the first tests for a couple having trouble conceiving), the value relates best to the number of small antral follicles on ultrasound.
Laboratories use limits per age for women, for example Star-SHL with 1.20 to 9.05 µg/l from 25 to 29 and 0.06 to 4.44 µg/l from 40 to 44. According to Star-SHL, women over 50 generally show an AMH below 0.03 µg/l.
According to the 2023 international PCOS guideline, AMH could be used in adult women to establish whether the ovaries are polycystic, with many small follicles. That guideline advises against using AMH as the single test for the diagnosis of PCOS (polycystic ovary syndrome), and says AMH should not yet be used in adolescents. Guidelines differ on that role: the Dutch 2023 PCOS guideline, an adaptation of the 2018 international text, advises against using AMH as a replacement for the ultrasound. The NVKC also combines AMH with an ultrasound.
In women of reproductive age with breast cancer, a 2017 study calls AMH a relevant tool to assess and follow the follicle supply during treatment.
Nothing special is needed for these tests.
Your cycle does not matter here
Good to knowThis value barely changes, including through a menstrual cycle. Any day works.
With suspected premature ovarian insufficiency, which the European guideline defines as the ovaries stopping before age 40, and when polycystic ovary syndrome (PCOS) is investigated, a doctor can request AMH, as before IVF treatment.
According to the European guideline on premature ovarian insufficiency, AMH is not the first test for that diagnosis, but it may help when the FSH (follicle-stimulating hormone) result is inconclusive.
In premature ovarian insufficiency, in which, according to the European guideline, the ovaries stop before age 40, AMH can be low; according to the European guideline, that diagnosis requires a raised FSH (follicle-stimulating hormone). AMH can also be low after surgery on an endometriosis cyst, and in women of reproductive age with breast cancer also after chemotherapy.
In women who kept a cycle after cancer treatment, an undetectably low AMH does not appear to be linked to reduced fertility according to the Dutch guideline for the basic fertility work-up.
In polycystic ovary syndrome (PCOS), with many small follicles in the ovaries, AMH can be strongly raised. According to the international PCOS guideline, the diagnosis is simpler when an irregular cycle and signs of too many male hormones are present together; in that case an ultrasound or AMH is not needed.
Age
The amount of AMH falls in women from a certain age, while FSH rises.
Premature ovarian insufficiency
In premature ovarian insufficiency, in which, according to the European guideline, ovarian function stops before age 40, AMH can be low. According to the European guideline, an AMH test may help confirm that diagnosis when the FSH result is inconclusive, but it is not the primary test.
Hormonal contraception
Users of hormonal contraception had on average about a quarter lower AMH values in one study than women not using hormonal contraception; that effect proved reversible.
Surgery on an endometriosis cyst
After removal of an endometriosis cyst, AMH fell on average in a review of studies, which suggests a possible negative effect on the egg supply, although the studies differed widely.
Chemotherapy for breast cancer
In women of reproductive age with breast cancer, AMH fell to undetectable levels during chemotherapy in most and generally stayed very low afterwards in most.
Polycystic ovary syndrome (PCOS)
In women with PCOS, AMH is strongly raised according to the NVKC, and according to the NVKC the result must be combined with a transvaginal ultrasound, an internal scan through the vagina, for the diagnosis.
Note which form of hormonal contraception you use when you have an AMH result assessed, because it can lower AMH. That also applies to progestogen-only forms, with a hormone similar to the body's own progesterone, such as the implant and the mini-pill.
Yes, a high AMH can fit polycystic ovary syndrome (PCOS), but AMH alone does not make that diagnosis. According to the international PCOS guideline, either AMH or an ultrasound may be used in adults to establish polycystic ovaries, but both tests should not be performed, to limit over-diagnosis. The NVKC, by contrast, combines the result with an ultrasound.
Yes, after removal of an endometriosis cyst, AMH fell on average by about 1.1 ng/ml, which is about 1.1 µg/l, in a review of studies. The authors see a possible negative effect on the egg supply in that, although the studies differed widely.
Probably not: the 2025 European guideline on ovarian stimulation for IVF (in vitro fertilisation) does not recommend AMH for predicting a pregnancy or the birth of a live child in IVF. According to that same guideline, AMH does help estimate how the ovaries respond to that stimulation.
Add us as a preferred source. Google will then show our articles more often in your search results and in AI overviews. You can turn this off again at any time.
That did not work. Please try again.
This marker is included in the following test panels.
An AMH test measures your anti-Müllerian hormone and gives insight into your ovarian reserve. Any cycle day works.
Ovarian reserve panel with AMH, FSH, LH, and Estradiol.
Screening covering key markers associated with PCOS.
Complete female IVF intake panel: ovarian reserve, thyroid, infectious screening, immunity serology, blood group and CBC.
Medical reviewer
Dr. Naimi oversees the medical standards behind our content and assessments.
Medical policyDoctor's Assessment Included
Every result includes a professional assessment from a BIG-registered doctor. For treatment decisions, discuss your results with your GP.
AMH (Anti-Müllerian Hormone)
€54,-
We use cookies to analyze site usage and measure ad effectiveness. Privacy Policy